Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent Cells-Reference-Cited by-同舟云学术

Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent Cells

Published:2019-12 Issue: Volume:15 Page:63-71
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Leinonen Hanna M.,Lipponen Eevi M.,Valkama Anniina J.,Hynynen Heidi,Oruetxebarria Igor,Turkki Vesa,Olsson Venla,Kurkipuro Jere,Samaranayake Haritha,Määttä Ann-Marie,Parker Nigel R.,Ylä-Herttuala Seppo,Lesch Hanna P.

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference28 articles.

1. Radiotherapy of Glioblastoma 15 Years after the Landmark Stupp’s Trial: More Controversies than Standards?;Kazda;Radiol. Oncol.,2018

2. Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial;Westphal;Lancet Oncol.,2013

3. Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?;Stepanenko;Cancers (Basel),2018

4. A Novel Tumor-Suppressor, CDH18, Inhibits Glioma Cell Invasiveness Via UQCRC2 and Correlates with the Prognosis of Glioma Patients;Bai;Cell. Physiol. Biochem.,2018

5. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy;Moolten;Cancer Res.,1986

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing lentiviral vector formulation conditions for efficient ex vivo transduction of primary human T cells in chimeric antigen receptor T-cell manufacturing;Cytotherapy;2024-09

2. Advances and opportunities in process analytical technologies for viral vector manufacturing;Biotechnology Advances;2024-09

3. Quasi-perfusion studies for intensified lentiviral vector production using a continuous stable producer cell line;Molecular Therapy - Methods & Clinical Development;2024-06

4. Continuous manufacturing of lentiviral vectors using a stable producer cell line in a fixed-bed bioreactor;Molecular Therapy - Methods & Clinical Development;2024-03

5. High-Titer Recombinant Adenovirus 26 Vector GMP Manufacturing in HEK 293 Cells with a Stirred Single-Use Bioreactor for COVID-19 Vaccination Purposes;ACS Omega;2023-10-02